Cigarette smoking, TB, and TNF inhibitors.
Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, California 92093-0943, USA.
J
J
Bieber
A
A
Kavanaugh
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications*; D004198:Disease Susceptibility; D006801:Humans; D000069285:Infliximab; D012907:Smoking / Q000009:adverse effects*; D014376:Tuberculosis / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab